Cicero IL 头颈鳞状细胞癌临床试验
6项针对 头颈鳞状细胞癌的研究正在 Cicero及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
招募中3 期
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 距离 9 英里
- Advocate High Tech Medical Park, Palos Heights · 距离 12 英里
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
招募中3 期
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 距离 9 英里
- Advocate High Tech Medical Park, Palos Heights · 距离 12 英里
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
招募中2 期
- Loyola University Medical Center, Maywood · 距离 5 英里
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
招募中2 期
- Loyola University Medical Center, Maywood · 距离 5 英里
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
招募中2 期
- Advocate Christ Medical Center, Oak Lawn · 距离 9 英里
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 距离 9 英里
- Advocate High Tech Medical Park, Palos Heights · 距离 12 英里
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- Northwestern Medicine Oak Brook, Oak Brook · 距离 9 英里
其他城市的 头颈鳞状细胞癌试验
- Houston, TX47 项研究
- Los Angeles, CA42 项研究
- Boston, MA40 项研究
- New York City, NY39 项研究
- Nashville, TN39 项研究
- St. Louis, MO28 项研究
- Arlington, VA26 项研究
- Chicago, IL26 项研究
- Philadelphia, PA26 项研究
- Atlanta, GA24 项研究
- San Antonio, TX22 项研究
- New Haven, CT22 项研究
Cicero的其他研究
- 非小细胞肺癌24 项研究
- 肺癌17 项研究
- 前列腺癌14 项研究
- 癌症（所有类型）13 项研究
- 乳腺癌11 项研究
- 急性髓系白血病11 项研究
- 结直肠癌10 项研究
- 膀胱癌8 项研究
- 黑色素瘤7 项研究
- 心血管疾病7 项研究
- 转移性癌症7 项研究
- 多发性骨髓瘤6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。